Lung cancer treatment in the era of immunotherapy

Lung cancer is among the most common malignant tumors that cause serious harm to humans.Despite the successes of chemotherapy,radiotherapy,and targeted therapy,the prognosis of lung cancer remains unsatisfactory.Fortunately,patients with lung cancer have found hope in immunotherapy,particularly,in immune checkpoint inhibitors(ICIs). inhibitors(ipilimumab and tremelimumab).